 |
Directeur, Unité de neurobiologie moléculaire, Institut Douglas
judes_dot_poirier_At_mcgill_dot_ca |
2001
Lehmann D. J., Wiebusch H., Marshall S. E., Johnston C., Warden D. R., Morgan K., Schappert K., Poirier J., Xuereb J., Kalsheker N., Welsh K. I., Smith A. D. (2001). HLA class I, II & III genes in confirmed late-onset Alzheimer's disease, Neurobiol Aging, 22(1), 71-7.
Petit-Turcotte C., Poirier J. (2001). Neurotransmitter in the Aging Brain . Dans Maddox G. L. (Éd.) , The encyclopedia of aging : a comprehensive resource in gerontology and geriatrics (pp. 343-346). Springer Publishing Co..
Petit-Turcotte C., Stohl S. M., Beffert U., Cohn J. S., Aumont N., Tremblay J., Dea D., Yang L., Poirier J., Shachter N. S. (2001). Apolipoprotein C-I expression in the brain in Alzheimer's disease, Neurobiol Dis, 8(6), 953-63.
Poirier J. (2001). Apolipoprotein E and Alzheimer's disease, Ann N Y Acad Sci, 972, 81-92.
Ramassamy C., Christen Y., Poirier J. (2001). Beta-amyloid peptide and apolipoprotein E in Alzheimer's disease . Dans Christen Y. (Éd.) , Advances in Ginko Biloba Extracts Research (pp. 72-89). Solal.
Ramassamy C., Krzywkowski P., Averill D., Lussier-Cacan S., Theroux L., Christen Y., Davignon J., Poirier J. (2001). Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain, Brain Res Mol Brain Res, 86(1-2), 76-83.
Valastro B., Ghribi O., Poirier J., Krzywkowski P., Massicotte G. (2001). AMPA receptor regulation and LTP in the hippocampus of young and aged apolipoprotein E-deficient mice, Neurobiol Aging, 22(1), 9-15.
Vaucher E., Aumont N., Pearson D., Rowe W., Poirier J., Kar S. (2001). Amyloid beta peptide levels and its effects on hippocampal acetylcholine release in aged, cognitively-impaired and -unimpaired rats, J Chem Neuroanat, 21(4), 323-9.
de Leon M. J., Convit A., Wolf O. T., Tarshish C. Y., DeSanti S., Rusinek H., Tsui W., Kandil E., Scherer A. J., Roche A., Imossi A., Thorn E., Bobinski M., Caraos C., Lesbre P., Schlyer D., Poirier J., Reisberg B., Fowler J. (2001). Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET), Proc Natl Acad Sci U S A, 98(19), 10966-71.
